Target intelligence / Profile preview

NLRP3 inflammasome (NLR family pyrin domain containing 3) (NLRP3)

Target
NLRP3
Molecular classification
Pattern recognition receptor, Inflammasome, NLR family, Cytosolic sensor
01

Overview

The innate immune pattern-recognition pathways stimulated by Alum adjuvant primarily center on the activation of the NLRP3 inflammasome, a multi-protein complex essential for sensing sterile stressors and pathogens (Eisenbarth et al., 2008). Alum (aluminum hydroxide or phosphate) functions by inducing the release of damage-associated molecular patterns (DAMPs), such as uric acid and host DNA, from stressed or dying cells (Kool et al., 2008). Upon phagocytosis, Alum crystals cause lysosomal destabilization and the release of cathepsin B, which serves as a trigger for NLRP3 assembly (Hornung et al., 2008). The assembled NLRP3 inflammasome recruits the adapter protein ASC and pro-caspase-1, leading to the proteolytic activation of caspase-1, which then processes the pro-inflammatory cytokines IL-1β and IL-18 into their mature forms (Li et al., 2008). These cytokines create a local inflammatory environment that enhances the recruitment of antigen-presenting cells and promotes a robust Th2-biased adaptive immune response. Additionally, Alum-induced DNA release can activate the STING (Stimulator of Interferon Genes) pathway, further contributing to its adjuvant properties (Marichal et al., 2011). While Alum is the most widely used vaccine adjuvant globally, its activation of these pathways is also implicated in the pathogenesis of various autoinflammatory and metabolic diseases.

Other names
CryopyrinNALP3CIAS1PYPAF1Caspase recruitment domain-containing protein 7Alum-responsive pathwayAluminum-induced pattern-recognition pathway
02

Mechanism of action

Alum stimulates innate immune pathways by inducing lysosomal rupture and the release of endogenous danger signals like uric acid and DNA, which trigger the NLRP3 inflammasome and STING pathways to promote cytokine secretion and adaptive immunity.

03

Biological functions

Immune responseInflammationCytokine processingPyroptosisAdjuvant activity
04

Disease associations

InflammationInfectionAutoinflammatory syndromesGoutType 2 diabetesNeurodegenerative disease
05

Safety considerations

Injection site reactionsGranuloma formationChronic inflammationPotential for autoimmune triggers in predisposed individuals
06

Interacting drugs

Aluminum hydroxide

5 more in the full profile.

07

Biomarkers

Interleukin-1 beta (IL-1β)Interleukin-18 (IL-18)Caspase-1C-reactive protein (CRP)

Beyond the preview

Go deeper on NLRP3 inflammasome (NLR family pyrin domain containing 3) (NLRP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NLRP3 inflammasome (NLR family pyrin domain containing 3) (NLRP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call